Sherine Abdelmawla - Akanocure

Angel Scale Biotech: Learn More

Sherine Abdelmawla, PhD, founded Akanocure Pharmaceuticalsto combine chemistryand AI in a platform for discovering effective drugs that can be easily produced at scale. The first use case is a cancer therapy. Great chat with a compelling founder.

Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish and Richardson.

Highlights:

• Sal Daher Introduces Sherine Abdelmawla
• What Akanocure Pharmaceuticals is Doing
• "... The challenge is ... logistically speaking, manufacturing antibodies, they have problems with pharmacokinetics. Can we have a small molecule that can do the job of that antibody? ..."
• Collaboration in the Lab Vs. Collaboration in the Field
• The Business Model for Akanocure
• "... interrupting the process that the cancer uses for hijacking the production of lipid fats to create its own version, a lipid shell that has particular features that make it really hard to detect the cancer..."
• Sherine's Backstory
• Why Research?
• “...Science is hard enough, but on top of it, doing science with inadequate resources…”
• Advice to the Audience

Topics: biotech, founding story, robotics/AI